Insider Selling: USANA Health Sciences, Inc. (USNA) Director Sells $706,847.76 in Stock
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 5,688 shares of USANA Health Sciences stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $124.27, for a total transaction of $706,847.76. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Shares of USANA Health Sciences stock opened at $123.50 on Friday. The stock has a market capitalization of $3.03 billion, a PE ratio of 30.42 and a beta of 0.64. USANA Health Sciences, Inc. has a 52-week low of $55.50 and a 52-week high of $137.95.
USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, July 24th. The company reported $1.36 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.25. The company had revenue of $301.50 million during the quarter, compared to analysts’ expectations of $278.41 million. USANA Health Sciences had a net margin of 7.16% and a return on equity of 29.50%. USANA Health Sciences’s quarterly revenue was up 17.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.98 earnings per share. sell-side analysts forecast that USANA Health Sciences, Inc. will post 4.9 EPS for the current year.
Several institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC boosted its position in shares of USANA Health Sciences by 7.3% in the second quarter. Renaissance Technologies LLC now owns 2,105,466 shares of the company’s stock valued at $242,760,000 after acquiring an additional 144,000 shares during the period. BlackRock Inc. boosted its position in shares of USANA Health Sciences by 16.0% in the second quarter. BlackRock Inc. now owns 962,366 shares of the company’s stock valued at $110,961,000 after acquiring an additional 133,076 shares during the period. Acadian Asset Management LLC bought a new stake in shares of USANA Health Sciences in the second quarter valued at about $103,349,000. Dimensional Fund Advisors LP boosted its position in shares of USANA Health Sciences by 1.9% in the first quarter. Dimensional Fund Advisors LP now owns 777,313 shares of the company’s stock valued at $66,771,000 after acquiring an additional 14,692 shares during the period. Finally, Millennium Management LLC boosted its position in shares of USANA Health Sciences by 121.4% in the second quarter. Millennium Management LLC now owns 186,974 shares of the company’s stock valued at $21,558,000 after acquiring an additional 102,529 shares during the period. 56.38% of the stock is owned by institutional investors.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Further Reading: Return on Investment (ROI) Defined, Explained
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.